Supplementary Material: Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma
Published: 19 January 2021| Version 1 | DOI: 10.17632/g769x5dt5r.1
Contributor:
Sophia Shalhout
Description
Supplementary Material: Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma Supplemental Detailed Methods Supplemental Table 1 Supplemental Figure 1
Files
Institutions
Harvard Medical School, Massachusetts General Hospital Cancer Center
Categories
Immunotherapy, Outcomes Research, Squamous Cell Carcinoma, Non-Melanoma Skin Cancer, Programmed Death-Ligand 1